Strain Name: |
B10.D2-Hc1 H2d H2-T18c/nSnJ-Tg(DO11.10)10Dlo/J |
|---|---|
Stock Number: |
003147 |
Availability: | Repository-Cryopreserved |
General Terms and Conditions |
| Former Name |
B10.D2-Hc1 H2d H2-T18c/nSnJ-Tg(DO11.10)10Loh/J (Changed: 15-DEC-04
) |
| Genes & Alleles | H2; H2-T18; H2d; Hc; Hc1; Tcra; Tcrb; Tg(DO11.10)10Dlo; ; |
Type JAX® GEMM® Strain - Congenic Additional information on JAX® GEMM® Strains. Type JAX® GEMM® Strain - Major Histocompatibility Congenic Type JAX® GEMM® Strain - Mutant Strain Type JAX® GEMM® Strain - Transgenic Species laboratory mouse Background Strain B10.D2-Hc1 H2d H2-T18c/nSnJ Donor Strain BALB/c-TgN(DO11.10)10Loh Donating Investigator Dennis Loh, Hoffman LaRoche Generation N16p Appearance
black
Related Genotype: a/aStrain Description
Clonal deletion of autoreactive T cells in vivo was studied using a peptide antigen to induce deletion of antigen-reactive thymocytes. Mice transgenic for a T cell receptor that reacts to this peptide (Tg(DO11.10)10Loh) contain thymocytes that progress from the immature to the mature phenotype. Intraperitoneal administration of the peptide antigen to transgenic mice results in a rapid deletion of the immature CD4+ CD8+ TCRlo thymocytes. Apoptosis of cortical thymocytes can be seen within 20 hours of treatment. These results provide direct evidence for the in vivo role of apoptosis in the development of antigen-induced tolerance.Strain Development
A transgenic construct containing the rearranged Vbeta 8.1 and Valpha 13 T cell receptor genes of chicken ovalbumin–specific T cell hybridoma DO11.10 was injected into fertilized B6C3F1 x BALB/c oocytes by Dr. Ken Murphy in the laboratory of Dr. Dennis Loh at Washington University, St. Louis in 1989. The founder animal was backcrossed to BALB/c 5-6 times before being transferred to NIH and crossed to B10.D2 for seven generations. The strain was donated to The Jackson Laboratory in 1998 where it was crossed once more with an NIH-supplied B10.D2 mouse. The offspring were mated to B10.D2-Hc1 H2d H2-T18c/nSnJ (Stock No. 000463) for 4 additional generations before being made homozygous.
Mammalian Phenotype Terms assigned by genotype |
| Allele Symbol | H2d | ||
|---|---|---|---|
| Allele Name | d variant | ||
| Gene Symbol and Name | H2, histocompatibility-2, MHC | ||
| Chromosome | 17 | ||
| Gene Common Name(s) | H-2; MHC-II; | ||
| General Note | The d variant has been observed in the following strains: DBA/2, DBA/2J BALB/c, BALB/cByJ, BALB/cJ, C57BLKS, NZB | ||
| Allele Symbol | Hc1 | ||
| Allele Name | sufficient | ||
| Common Name(s) | C5 sufficient; C5-s; C5-suf; | ||
| Gene Symbol and Name | Hc, hemolytic complement | ||
| Chromosome | 2 | ||
| Gene Common Name(s) | C5; C5a; CPAMD4; FLJ17816; FLJ17822; He; MGC142298; | ||
| General Note |
Hc was identified as a candidate gene for Abhr2 in a microarray analysis of lung mRNA from A/J, C3H/HeJ, and (A/J x C3H/HeJ)F1 x A/J backcross animals. Hc genotype shows statistically significant correlation to allergen-induced bronchial hyperresponsive phenotype. The C3H/HeJ allele does not have the 2 bp deletion and is associated with resistance to allergen-induced bronchial hyperresponsiveness. (J:108211) | ||
| Molecular Note | This allele does not contain the 2 base "TA" deletion found in the Hc0 allele and is found in the following mouse strains BALB/cJ, C57BL/6J, DBA/1J, and B10.D2/nSnJ. This is equivalent to the wild-type allele. [J:23983] | ||
| Allele Symbol | Tg(DO11.10)10Dlo | ||
| Allele Name | transgene insertion 10, Dennis Y Loh | ||
| Common Name(s) | CO11.10 TCR-alphabeta; DO-11.10; DO-Tg; DO.10 Tg; DO.11; DO.11.10 TCR; DO11; DO11 TCR; DO11.10 TCR; DO11.10 TCR Tg; DO11.10 alphabeta-TCR; DO11.10TCRalphabeta; Do11.10 alphabeta TCR; Do11.10 alphabetaTCR; Tg(DO11.10)Tcra/Tcrb; TgN(DO11.10)10Loh; | ||
| Mutation Made By | Dennis Loh, Hoffman LaRoche | ||
| Expressed Gene | Tcra, T-cell receptor alpha chain, mouse, laboratory | ||
| Expressed Gene | Tcrb, T-cell receptor beta chain, mouse, laboratory | ||
| General Note |
Mice carrying this MHC class II restricted rearranged T cell receptor transgene on a H2d background react to ovalbumin (OVA) peptide antigen. Intraperitoneal administration of OVA to transgenic mice results in a rapid deletion of the immature CD4+ CD8+ TCRlo thymocytes with progression to mature thymocytes. Apoptosis of cortical thymocytes in these mice occurs within 20 hours of treatment. | ||
| Molecular Note | The transgene contains rearranged Tcra and Tcrb genes and is expressed in the majority of T cells. These rearranged transgenes encode a chicken ovalbumin-specific MHC class II (I-Ad)-restricted T cell receptor. [J:25536] [J:61321] | ||
| Gene Symbol and Name | H2-T18, histocompatibility 2, T region locus 18 | ||
| Chromosome | 17 | ||
| Gene Common Name(s) | H-2T18; TL Ag; Tla; thymus leukemia antigen; | ||
| Control | ||
|---|---|---|
| Noncarrier | ||
| 000463 B10.D2-Hc1 H2d H2-T18c/nSnJ | ||
| Considerations for Choosing Controls | ||
Tg(DO11.10)10Dlo
| Diet Information | LabDiet® 5K52/5K67 |
|---|
Strains carrying H2d allele
005308 B10.Cg-H2d Tg(TcraCl4,TcrbCl4)1Shrm/ShrmJ 005534 B10.Cg-H2d Tg(Ins2-HA)165Bri/ShrmJ 005895 B10.Cg-Thy1a H2d Tg(TcraCl1,TcrbCl1)1Shrm/J 000462 B10.D2-H2d/n2SnJ 000460 B10.D2-Hc0 H2d H2-T18c/o2SnJ 000461 B10.D2-Hc0 H2d H2-T18c/oSnJ 000463 B10.D2-Hc1 H2d H2-T18c/nSnJ 000360 B6.C-H2d Mdmg1BALB/cBy/aByJ 000359 B6.C-H2d/bByJ 001893 BRVR.D2-H2d/J 000437 D1.C-H2d H2-T18c/SnJ 003153 WLC.C-H2d.GR-Mtv2/MorJ 003154 WLC.C-H2d/MorJ View Strains carrying H2d (13 strains)
Strains carrying Hc1 allele
000470 AK.M-H2m H2-T18a/nSnJ 005308 B10.Cg-H2d Tg(TcraCl4,TcrbCl4)1Shrm/ShrmJ 000463 B10.D2-Hc1 H2d H2-T18c/nSnJ 004306 NOD.CBALs-Hc1/LtJ View Strains carrying Hc1 (4 strains)
Strains carrying Tg(DO11.10)10Dlo allele
003303 C.Cg-Tg(DO11.10)10Dlo/J View Strains carrying Tg(DO11.10)10Dlo (1 strain)
Congenic Nomenclature
Tcra relatedImmunology and Inflammation Research
Rearranged Antigen-Specific T Cell Receptor Transgenes (class II restricted)
Research Tools
Immunology and Inflammation Research (T Cell Receptor Transgenics)
Tcrb relatedHematological Research
Immunological Defects
Immunology and Inflammation Research
Immunodeficiency
Inflammation
T Cell Receptor Signaling Defects
Research Tools
Cancer Research (specific T cell deficiency)
H2d relatedHematological Research
Immunological Defects
Immunology and Inflammation Research
Immunodeficiency
Inflammation
T Cell Receptor Signaling Defects
Hc1 relatedImmunology and Inflammation Research
CD Antigens, Antigen Receptors, and Histocompatibility Markers
Immunodeficiency (specific complement deficiency) (control)
Research Tools
Immunology and Inflammation Research (specific complement deficiency) (C5 complement) (control)
Selected Reference(s)
Additional ReferencesMurphy KM; Heimberger AB; Loh DY. 1990. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science 250(4988):1720-3. [PubMed: 2125367] [J:70572]
| Strain Name: | B10.D2-Hc1 H2d H2-T18c/nSnJ-Tg(DO11.10)10Dlo/J |
| Stock Number: | 003147 |
IMPORTANT NOTE: Prices are based on shipping destination. To view prices, select your shipping destination.
| Standard Supply | Repository-Cryopreserved. Must Be Recovered. Please refer to the Supply Notes for further information. |
|---|---|
| Supply Notes |
Cryorecovery - Standard. The recovery process begins when a signed agreement form is returned to the Customer Service Department after order placement. Although results vary by strain, at least two males and two females (two pairs) will be provided, typically within 15 weeks of our receipt of the signed agreement form. If the first recovery attempt is unsuccessful or only one pair is recovered, a second recovery will be done, extending the delivery time to approximately 25 weeks. At least one member of each pair will be of known genotype and will carry the mutation if it is a mutant strain. Please note that pairs may not reflect the mating scheme utilized by The Jackson Laboratory prior to cryopreservation of the strain. Mating schemes are sometimes modified for successful cryopreservation. Price represents a repository maintenance fee, which includes the cost of recovery of the strain from the cryopreservation resource and the periodic replacement of the frozen embryos used for recovery. Cryorecovery to establish a Dedicated Supply for greater quantities of mice. |
| Licensing | See General Terms and Conditions below |
| Control Information | View Control Information in Strain Details. |
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form